Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)
South Korea
· Delayed Price · Currency is KRW 4,060.00
-540.00 (-11.74%)
Dec 19, 2024, 3:00 PM KST
Bridge Biotherapeutics Market Cap
Bridge Biotherapeutics has a market cap or net worth of 170.61 billion as of December 20, 2024. Its market cap has increased by 133.38% in one year.
Market Cap
170.61B
Enterprise Value
150.64B
Revenue
1.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,060.00
Market Cap Chart
Since March 22, 2021, Bridge Biotherapeutics's market cap has decreased from 300.48B to 170.61B, a decrease of -43.22%. That is a compound annual growth rate of -14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 170.61B | 112.78% |
| Dec 28, 2023 | 80.18B | -71.06% |
| Dec 29, 2022 | 277.06B | -17.02% |
| Dec 30, 2021 | 333.88B | 11.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition